Search Results
Jul 19, 2019, 2:28 PM
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD (ReSolve FSHD).
Jul 18, 2019, 8:43 PM
DUX4 suppresses MHC Class I to promote cancer immune evasion and resistance to checkpoint blockade.
Connect with us on social media